Leadership Overview
PT. Inertia Utama has 4 executives leading key functions including technology, operations, strategy, and governance.
Driven by a commitment to excellence, PT. Inertia Utama operates within the pharmaceutical industry, focusing on delivering high-quality products and fostering innovation to meet market demands.
Driven by a commitment to excellence, PT. Inertia Utama operates within the pharmaceutical industry, focusing on delivering high-quality products and fostering innovation to meet market demands.
Leadership Roles at PT. Inertia Utama
Hery Sutanto - President & Director
Hery Sutanto, the President & Director at PT. Inertia Utama, spearheads the company's strategic vision and overall corporate direction. This leadership position involves setting ambitious goals for growth and innovation within the pharmaceutical sector. Hery Sutanto directs executive teams, ensuring cohesive strategy implementation across all business units. The President & Director's responsibilities encompass market expansion initiatives, fostering key partnerships, and driving financial performance. By providing decisive leadership, Hery Sutanto guides PT. Inertia Utama's trajectory, focusing on enhancing its market position and operational excellence. This role is pivotal in navigating industry challenges and capitalizing on emerging opportunities to secure long-term success and stakeholder value.
Raymond Tjandrawinata - President & Commissioner
Raymond Tjandrawinata, the President & Commissioner at PT. Inertia Utama, provides high-level oversight and strategic guidance, ensuring corporate governance and long-term sustainability. This executive role focuses on the strategic direction and ethical operations of the company within the pharmaceutical industry. Raymond Tjandrawinata chairs key board meetings, reviewing performance metrics and approving major corporate decisions. The President & Commissioner's responsibilities include safeguarding shareholder interests and ensuring compliance with regulatory standards. By offering expert counsel and strategic vision, Raymond Tjandrawinata influences PT. Inertia Utama's market positioning and commitment to innovation, driving the company towards sustained success and industry leadership.
Wimala Widjaja - Chief Information Officer
Wimala Widjaja, the Chief Information Officer at PT. Inertia Utama, directs the company's technology strategy and digital transformation initiatives. Overseeing all IT infrastructure, Wimala Widjaja ensures the seamless integration of systems that support PT. Inertia Utama's pharmaceutical operations. This leadership role involves managing data security, implementing advanced analytics for operational efficiency, and driving innovation in technological solutions. The Chief Information Officer's responsibilities extend to optimizing software development lifecycles and maintaining robust cybersecurity protocols to safeguard sensitive company and customer data. By championing new technologies, Wimala Widjaja enhances the company's competitive edge within the Indonesian pharmaceutical sector, ensuring technological advancements align with business objectives and contribute to overall growth and market presence.
Ferry Soetikno - Direktur
Ferry Soetikno, the Direktur at PT. Inertia Utama, manages critical operational functions and drives strategic execution across the organization. This executive directs day-to-day business activities, ensuring alignment with the company's overarching goals in the pharmaceutical industry. Ferry Soetikno's purview includes overseeing production processes, supply chain management, and quality control to maintain the highest standards for PT. Inertia Utama's products. The Direktur's role involves fostering cross-departmental collaboration to enhance operational efficiency and implement best practices. By focusing on process optimization and resource allocation, Ferry Soetikno contributes significantly to the company's ability to meet market demands and achieve sustainable growth within the competitive Indonesian pharmaceutical landscape.
Explore Leadership Teams in Manufacturing
Founded in 1998, Aldevron is a biotechnology privately held company that develops and manufactures plasmid DNA, proteins, enzymes, and antibodies. Aldevron is located in North Dakota.
Company Leadership MC

LG
JM
Tolmar Pharmaceuticals is a fully integrated pharmaceutical company focused on the innovative development, manufacturing, and commercialization of specialty pharmaceuticals across multiple therapeutic areas, including Urology. Tolmar global headquarters, product development and manufacturing facilities are based in Northern Colorado, while North America commercial headquarters is based in Buffalo Grove, Illinois.
Company Leadership AD
AC
SS
Integrace Health is a therapy-focused healthcare company based in India, specializing in innovative solutions for Musculoskeletal Disorders, Pain Management, and Women's Health. Founded in 2018, it has quickly risen to become one of India's top 70 pharmaceutical companies, with five brands ranked #1 in their respective therapy areas. The company aims to significantly impact the health and well-being of the Indian population and envisions becoming a transformative force in the healthcare landscape by 2030. Integrace Health is committed to innovation, disciplined execution, and inspiring collaboration among its stakeholders.
Company Leadership KR
SS
AA
AN
Lotus Pharmaceutical is a global pharmaceutical company focused on developing, manufacturing, and commercializing generic and specialty medicines. It operates research and manufacturing facilities across Asia and supplies treatments for areas such as oncology, cardiovascular disease, and central nervous system conditions, aiming to improve access to affordable healthcare worldwide.
Company Leadership BS
VK
EC